|
Re: ASN late breaker and CKD sub-study top-line
|
11
|
Resverlogix Corp.
|
Oct 09, 2019 08:54PM
|
|
3 Presentations March 26-March 30, 2020
|
11
|
Resverlogix Corp.
|
Feb 20, 2020 02:05PM
|
|
Answers from IR
|
11
|
Resverlogix Corp.
|
Jun 07, 2018 11:05PM
|
|
Re: Constellation Pharma
|
11
|
Resverlogix Corp.
|
Jun 30, 2020 10:24AM
|
|
Re: Clarification on BETonMACE baseline data
|
11
|
Resverlogix Corp.
|
Sep 04, 2019 12:53PM
|
|
Re: Who removed my post?
|
11
|
Resverlogix Corp.
|
Nov 17, 2020 03:39PM
|
|
Re: Enrichment
|
11
|
Resverlogix Corp.
|
Jul 12, 2020 09:01AM
|
|
CTAD Asia Alzheimer's Conference Sept 1 & 2
|
11
|
Resverlogix Corp.
|
Sep 01, 2018 09:25AM
|
|
Re: Estimated Glomerular Filtration Rate
|
11
|
Resverlogix Corp.
|
Nov 17, 2019 05:08PM
|
|
Re: 3600 patient years
|
11
|
Resverlogix Corp.
|
Feb 20, 2018 04:34PM
|
|
Gordon Research Conference Presentation Thursday June 14th
|
11
|
Resverlogix Corp.
|
Jun 12, 2018 12:20PM
|
|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
11
|
Resverlogix Corp.
|
Mar 31, 2020 12:32PM
|
|
Re: Positives vs. negatives
|
11
|
Resverlogix Corp.
|
Nov 20, 2019 12:43PM
|
|
Re: Publication / Resverlogix An Author
|
11
|
Resverlogix Corp.
|
Aug 20, 2019 01:53PM
|
|
A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
11
|
Resverlogix Corp.
|
Sep 24, 2015 11:07PM
|
|
Re: Drip
|
11
|
Resverlogix Corp.
|
Aug 04, 2015 03:52PM
|
|
Re: Web replay of Yale Presentation from NYC...
|
11
|
Resverlogix Corp.
|
Sep 29, 2015 11:13AM
|
|
Re: Could there be another shoe waiting to drop?
|
11
|
Resverlogix Corp.
|
May 18, 2019 11:18AM
|
|
Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
|
11
|
Resverlogix Corp.
|
Apr 27, 2021 01:46PM
|
|
Re: Slide 27 - I would get rid of it....
|
11
|
Resverlogix Corp.
|
Sep 17, 2016 03:32PM
|
